The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikeda, H.
Right arrow Articles by Matozaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikeda, H.
Right arrow Articles by Matozaki, T.
The Journal of Immunology, 2006, 177: 3123-3132.
Copyright © 2006 by The American Association of Immunologists, Inc.

Mutational Analysis of the Mechanism of Negative Regulation by Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 of Phagocytosis in Macrophages1

Hiroshi Ikeda*, Hideki Okazawa*, Hiroshi Ohnishi*, Yoji Murata*, Per-Arne Oldenborg{dagger} and Takashi Matozaki2,*

* Laboratory of Biosignal Sciences, Institute for Molecular and Cellular Regulation, Gunma University, Gunma, Japan; and {dagger} Department of Integrative Medical Biology, Section for Histology and Cell Biology, Umeå University, Umeå, Sweden

Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 (SHPS-1) is a transmembrane protein predominantly expressed in macrophages. The binding of CD47 on RBCs to SHPS-1 on macrophages is implicated in inhibition of phagocytosis of the former cells by the latter. We have now shown that forced expression in mouse RAW264.7 macrophages of a mutant version (SHPS-1-4F) of mouse SHPS-1, in which four tyrosine phosphorylation sites are replaced by phenylalanine, markedly promoted Fc{gamma}R-mediated phagocytosis of mouse RBCs or SRBCs. Forced expression of another mutant form (SHPS-1-{Delta}Cyto) of mouse SHPS-1, which lacks most of the cytoplasmic region, did not promote such phagocytosis. Similarly, forced expression of a rat version of SHPS-1-4F, but not that of rat wild-type SHPS-1 or SHPS-1-{Delta}Cyto, in RAW264.7 cells enhanced Fc{gamma}R-mediated phagocytosis of RBCs. Tyrosine phosphorylation of endogenous SHPS-1 as well as its association with Src homology 2 domain-containing protein tyrosine phosphatase-1 were not markedly inhibited by expression of SHPS-1-4F. Furthermore, the attachment of IgG-opsonized RBCs to RAW264.7 cells was markedly increased by expression of SHPS-1-4F, and this effect did not appear to be mediated by the interaction between CD47 and SHPS-1. These data suggest that inhibition by SHPS-1 of phagocytosis in macrophages is mediated, at least in part, in a manner independent of the transinteraction between CD47 and SHPS-1. In addition, the cytoplasmic region as well as tyrosine phosphorylation sites in this region of SHPS-1 appear indispensable for this inhibitory action of SHPS-1. Moreover, SHPS-1 may regulate the attachment of RBCs to macrophages by an as yet unidentified mechanism.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas Cancer, a Grant-in-Aid for Scientific Research (B), a Grant-in-Aid for Young Scientists, and a 21st Century Center of Excellence Program grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, as well as by grants from the Swedish Research Council (31X-14286), the National Institutes of Health (GM57573-06), the Swedish Society of Medicine, the Faculty of Medicine of Umeå University, the Suzuken Memorial Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Astellas Foundation for Research on Medical Resources.

2 Address correspondence and reprint requests to Dr. Takashi Matozaki, Laboratory of Biosignal Sciences, Institute for Molecular and Cellular Regulation, Gunma University, 3-39-15 Showa-Machi, Maebashi, Gunma 371-8512, Japan. E-mail address: matozaki{at}showa.gunma-u.ac.jp

3 Abbreviations used in this paper: SHP, Src homology 2 domain-containing protein tyrosine phosphatase; WT, wild type; PEM, peritoneal macrophage; SHPS-1, SHP substrate-1.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. S. Isenberg, D. D. Roberts, and W. A. Frazier
CD47: A New Target in Cardiovascular Therapy
Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 615 - 621.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
A. Miyake, Y. Murata, H. Okazawa, H. Ikeda, Y. Niwayama, H. Ohnishi, Y. Hirata, and T. Matozaki
Negative regulation by SHPS-1 of Toll-like receptor-dependent proinflammatory cytokine production in macrophages.
Genes Cells, February 1, 2008; 13(2): 209 - 219.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.